ArisGlobal Announces Continued Growth with New Global Offices
Organization Opens New Offices in Belgium and Ireland
STAMFORD, CT—JUNE 25, 2012—ArisGlobal, a provider of solutions to the life science industry, announced the opening of two new offices in Antwerp, Belgium and Dublin, Ireland.
These new offices will allow the company to continue its growth and expansion in several product areas including pharmacovigilance and risk management, clinical data management and operations, regulatory affairs, and medical information management.
“We continue to grow with the addition of new customers and the development of new products and offerings. This expansion has created the need for an even broader global presence and new space in several regions of the world,” commented Vice President of European Operations, Simon Sparkes. “This expansion will help us to deliver added value to our customers and further execute on our vision of a suite of integrated life science software and services meeting the diverse needs of organizations around the world.”
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Final ENLIVEN Trial Results Confirm Long-Term Benefit of Turalio in Tenosynovial Giant Cell Tumor
July 9th 2025In final data from the Phase III ENLIVEN study, Turalio (pexidartinib) demonstrated durable tumor responses and a consistent safety profile in patients with symptomatic TGCT not amenable to surgery.
